Taurine supplementation and diabetes mellitus

Area of Science:

• Biochemistry
• Endocrinology
• Nutritional Science

Background:

• Taurine, a sulfur amino acid from methionine and cysteine metabolism, is investigated for its role in diabetes mellitus and insulin resistance.
• Perinatal taurine administration is explored as a potential preventative measure for diabetes and insulin resistance.

Purpose of the Study:

• To review experimental and clinical evidence on taurine's effects in type 1 and type 2 diabetes mellitus and insulin resistance.
• To assess the potential of taurine in preventing diabetes mellitus and improving metabolic parameters.

Main Methods:

• Review of experimental studies in animal models of diabetes and insulin resistance.
• Analysis of limited clinical trials investigating taurine supplementation.

Main Results:

• Experimental data indicate taurine may reduce organ lipid peroxidation and plasma lipids, with notable effects on retina, lens, and nerves.
• Alterations in taurine homeostasis are observed in type 2 diabetes and insulin resistance models.
• Taurine administration prevented diabetes onset in NOD mice and improved glucose tolerance in adults.

Conclusions:

• While experimental data are promising, current clinical studies are insufficient to establish taurine's therapeutic significance.
• Further rigorous experimental and clinical research is necessary to evaluate taurine's therapeutic potential in diabetes and insulin resistance.
• Standardization of taurine concentrations, patient selection, and study endpoints are crucial for future research.